MECP2 and Rett syndrome: Two Mecp2 null mice obtained with Cre-LoxP technology and carrying an ubiquitous deletion, were viable but affected by severe neurological symptoms characteristic of RTT (Chen et al., 2001; Guy et al., 2001).